June 24, 2024 · Form 4 insider transaction
Murray Dallan sold 2,352 shares of Sarepta Therapeutics, Inc. at $164.64 per share, a transaction worth $387.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024.